1. Home
  2. REAL vs VNDA Comparison

REAL vs VNDA Comparison

Compare REAL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$9.21

Market Cap

1.1B

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.15

Market Cap

373.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
VNDA
Founded
2011
2002
Country
United States
United States
Employees
N/A
533
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
373.4M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
REAL
VNDA
Price
$9.21
$6.15
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$17.00
$14.90
AVG Volume (30 Days)
3.9M
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
43.55
N/A
EPS
N/A
N/A
Revenue
$692,845,000.00
$216,105,000.00
Revenue This Year
$14.30
$21.35
Revenue Next Year
$10.15
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
15.38
8.72
52 Week Low
$4.71
$4.14
52 Week High
$17.39
$9.91

Technical Indicators

Market Signals
Indicator
REAL
VNDA
Relative Strength Index (RSI) 38.92 38.46
Support Level $8.05 $5.73
Resistance Level $11.48 $7.76
Average True Range (ATR) 0.69 0.29
MACD -0.21 -0.03
Stochastic Oscillator 10.64 12.18

Price Performance

Historical Comparison
REAL
VNDA

About REAL The RealReal Inc.

The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: